日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors

TTI-101(一种首创的口服STAT3抑制剂)治疗晚期实体瘤患者的I期临床试验

Tsimberidou, Apostolia M; Vining, David J; Arora, Sukeshi P; de Achaval, Sofia; Larson, Jeffrey; Kauh, John; Cartwright, Carrie; Avritscher, Rony; Alibhai, Imran; Tweardy, David J; Kaseb, Ahmed O

Barriers to Offering Organ Preservation for Rectal Cancer in a Predominantly Hispanic Safety Net Hospital

在以西班牙裔为主的公立医院中,为直肠癌患者提供器官保留治疗面临的障碍

Nasim, Bilal W; Murphy, Samantha; Yracheta, Jaclyn; Clark, Austen Lee; Veluri, Shriya L; Katabathina, Venkata; Parikh, Alexander; Campi, Haisar Dao; Feferman, Yael; Russell, Tara A; Arora, Sukeshi P; Newman, Neil; Logue, Alicia J; Court, Colin M

Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Administration

退伍军人健康管理局治疗的局部晚期/转移性肝细胞癌患者的临床特征、治疗模式和预后

Alkadimi, Munaf A; Aldawoodi, Tamarah A; Lucero, Kana T; Fierro, Maria E; Boyle, Lauren D; Mader, Michael J; Franklin, Kathleen R; Arora, Sukeshi P; Nooruddin, Zohra

Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas

德克萨斯州南部一家以少数族裔为主的癌症中心,拉丁裔和非拉丁裔白人胃癌患者的临床病理差异和死亡率

Williams, Madison H; Williams, Ryan A; Hernandez, Brian; Michalek, Joel; Long Parma, Dorothy; Arora, Sukeshi P